Clinical Trial Update: Pilot Trial of Ustekinumab for Primary Sjögren's Syndrome [Phase 1]

View source ↗

Summary

A Phase 1 pilot trial evaluating ustekinumab for Primary Sjögren's Syndrome has completed and posted results in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• Stelara (ustekinumab)

Snippet

Sponsor: University of Rochester | Conditions: Primary Sjögren Syndrome | Phase 1 | Status: COMPLETED | Results posted: 2024-06-25